John Y. Televantos - 08 Feb 2023 Form 4 Insider Report for BALCHEM CORP (BCPC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Feb 2023, 16:20:16 UTC
Prior SEC filing
16 Feb 2022
Next SEC filing
15 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Travis Larsen, Attorney in Fact for John Y. Televantos

Key filing fact

John Y. Televantos filed Form 4 for BALCHEM CORP (BCPC) on 10 Feb 2023.

Key facts

  • This page summarizes John Y. Televantos's Form 4 filing for BALCHEM CORP (BCPC).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 10 Feb 2023, 16:20.

Change

  • Previous filing in this sequence was filed on 16 Feb 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCPC transaction

Common Stock

Award

Transaction value
$0
Shares
+530
Change %
+1.8%
Price
$0.000000
Shares after
29,336
Date
08 Feb 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BCPC transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+1,790
Change %
Price
$0.000000
Shares after
1,790
Date
08 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,790
Exercise price
$138.09
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

Footnote F2

Options vest 20% Year 1; 40% Year 2; and 40% Year 3

SEC remarks

Exhibit 24 - Power of Attorney is attached.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .